FDA Patent Listing Review System Suggested By Paxil Appeals Court
An FDA system for review of patents for "Orange Book" listing would be feasible, U.S. Federal Circuit Judge Jay Plager suggested Feb. 4
An FDA system for review of patents for "Orange Book" listing would be feasible, U.S. Federal Circuit Judge Jay Plager suggested Feb. 4